Table 2 Clinicopathological features of CRCs
From: An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues
Characteristic | n (%) |
|---|---|
Age (years), median (range) | 62 (19–93) |
Sex | |
Female | 62 (34.3) |
Male | 119 (65.7) |
Tumor location | |
Right colon | 64 (35.4) |
Left colon | 113 (62.4) |
Other/undetermined | 3 (1.7) |
Synchronous tumor | 1 (0.6) |
Total | 181 |
Sizea (cm), mean (range) | 5.523 (1.7–15) |
Stageb | |
I | 13 (8.4) |
II | 49 (31.8) |
III | 44 (28.6) |
IV | 48 (31.2) |
Status | |
Alive | 133 (73.5) |
Deceased | 48 (26.5) |
Follow-up durationc (days) median (range) | |
994 (5–4978) | |
β-catenin mutation status via IHC | |
Present | 35 (19.33) |
Absent | 146 (80.66) |
